Mr. Pierre Devaux

Pharmacist - CEO Theraxel-Point Forty Five

Theraxel-Point Forty Five is a Company specialized in consulting, technical assistance, regulatory audits and training around the control of the chemical risk, Microbiological, particulate and pyrogenic for non-sterile, sterile and biotechnological pharmaceutical industries as well as related industries such as cosmetic industries. - Specialist in Part I, Annex 1 and Annex 15 of the European GMP, ICHQ9 and FDA guidelines on aseptic and validation processes and ISO22716- For 6 years, responsible for the quality control laboratories and the management of the environmental monitoring of the ZAC of the Excelvision Fareva French site;- For 5 years, Qualified Person/Quality Director of the ACM Pharma French laboratory, while carrying out consulting missions via the company UPS Consultants.- Head within the French Association A3P of the Common Interest Group on GMP Annex 15 and Cleaning Validation. Speaker for ISPE Nordic and Trainer for A3P Services as well as for Key2Compliance AB.